TY - JOUR
T1 - Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications
AU - Sohn, William
AU - Resnick, Matthew J.
AU - Greenfield, Sheldon
AU - Kaplan, Sherrie H.
AU - Phillips, Sharon
AU - Koyama, Tatsuki
AU - Goodman, Michael
AU - Hamilton, Ann S.
AU - Hashibe, Mia
AU - Hoffman, Karen E.
AU - Paddock, Lisa E.
AU - Stroup, Antoinette M.
AU - Wu, Xiao Cheng
AU - Penson, David F.
AU - Barocas, Daniel A.
N1 - Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background and Objective: Quality measures used in pay-forperformance systems are intended to address specific quality goals, such as safety, efficiency, effectiveness, timeliness, equity, and patient-centeredness. Given the small number of narrowly focused measures in prostate cancer care, we sought to determine whether adherence to any of the available payer-driven quality measures influences patient-centered outcomes, including health-related quality of life (HRQOL), patient satisfaction, and treatment-related complications. Methods: The Comparative Effectiveness Analysis of Surgery and Radiation study is a population-based, prospective cohort study that enrolled 3708 men with clinically localized prostate cancer during 2011 and 2012, of whom 2601 completed the 1-year survey and underwent complete chart abstraction. Compliance with 6 quality indicators endorsed by national consortia was assessed. Multivariable regression was used to determine the relationship between indicator compliance and Expanded Prostate Cancer Index Composite (EPIC- 26) instrument summary scores, satisfaction scale scores (service satisfaction scale for cancer care), and treatment-related complications. Results: Overall rates of compliance with these quality measures ranged between 64% and 88%. Three of the 6 measures were weakly associated with 1-year sexual function and bowel function scores (β = -4.6, 1.69, and 2.93, respectively; P ≤ 0.05), whereas the remaining measures had no significant relationship with patientreported HRQOL outcomes. Satisfaction scores and treatment-related complications were not associated with quality measure compliance. Conclusions: Compliance with available nationally endorsed quality indicators, which were designed to incentivize effective and efficient care, was not associated with clinically important changes in patient-centered outcomes (HRQOL, satisfaction, or complications) within 1-year.
AB - Background and Objective: Quality measures used in pay-forperformance systems are intended to address specific quality goals, such as safety, efficiency, effectiveness, timeliness, equity, and patient-centeredness. Given the small number of narrowly focused measures in prostate cancer care, we sought to determine whether adherence to any of the available payer-driven quality measures influences patient-centered outcomes, including health-related quality of life (HRQOL), patient satisfaction, and treatment-related complications. Methods: The Comparative Effectiveness Analysis of Surgery and Radiation study is a population-based, prospective cohort study that enrolled 3708 men with clinically localized prostate cancer during 2011 and 2012, of whom 2601 completed the 1-year survey and underwent complete chart abstraction. Compliance with 6 quality indicators endorsed by national consortia was assessed. Multivariable regression was used to determine the relationship between indicator compliance and Expanded Prostate Cancer Index Composite (EPIC- 26) instrument summary scores, satisfaction scale scores (service satisfaction scale for cancer care), and treatment-related complications. Results: Overall rates of compliance with these quality measures ranged between 64% and 88%. Three of the 6 measures were weakly associated with 1-year sexual function and bowel function scores (β = -4.6, 1.69, and 2.93, respectively; P ≤ 0.05), whereas the remaining measures had no significant relationship with patientreported HRQOL outcomes. Satisfaction scores and treatment-related complications were not associated with quality measure compliance. Conclusions: Compliance with available nationally endorsed quality indicators, which were designed to incentivize effective and efficient care, was not associated with clinically important changes in patient-centered outcomes (HRQOL, satisfaction, or complications) within 1-year.
KW - health-related quality of life
KW - patient-centered, PQRS
KW - prostate cancer
KW - quality
UR - http://www.scopus.com/inward/record.url?scp=84970021780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84970021780&partnerID=8YFLogxK
U2 - 10.1097/MLR.0000000000000562
DO - 10.1097/MLR.0000000000000562
M3 - Article
C2 - 27219634
AN - SCOPUS:84970021780
SN - 0025-7079
VL - 54
SP - 738
EP - 744
JO - Medical care
JF - Medical care
IS - 8
ER -